Jubilant Ingrevia Limited Total Liabilities

Latest as of September 2025: Rs22.16 Billion INR ≈ $239.62 Million USD

Jubilant Ingrevia Limited total liabilities. Based on the latest financial reports, Jubilant Ingrevia Limited (JUBLINGREA) has total liabilities worth Rs22.16 Billion INR (≈ $239.62 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check JUBLINGREA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Jubilant Ingrevia Limited (2020–2025)

Total liabilities of Jubilant Ingrevia Limited from 2020 to 2025. This chart illustrates how Jubilant Ingrevia Limited's total liabilities have evolved over time, based on quarterly financial data.

Jubilant Ingrevia Limited Competitors by Total Liabilities

The table below lists competitors of Jubilant Ingrevia Limited ranked by their total liabilities.

Company Country Total Liabilities
Sumavision Technologies
SHE:300079
China CN¥431.64 Million
BLS International Services Limited
NSE:BLS
India Rs9.00 Billion
East China Engineering Science and Technology Co Ltd
SHE:002140
China CN¥11.29 Billion
Yatharth Hospital & Trauma Care Services Limited
NSE:YATHARTH
India Rs4.74 Billion
Blue Square Real Estate Ltd
TA:BLSR
Israel ILA8.21 Billion
China Harzone Industry Corp Ltd
SHE:300527
China CN¥762.17 Million
Pentamaster Corporation Bhd
KLSE:7160
Malaysia RM301.71 Million
Solarvest Holdings Bhd
KLSE:0215
Malaysia RM615.61 Million

Liability Composition Analysis (2020–2025)

This chart breaks down Jubilant Ingrevia Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Jubilant Ingrevia Limited's balance sheet.

Liquidity & Leverage Metrics

Jubilant Ingrevia Limited Total Liabilities Ratios Explained

Jubilant Ingrevia Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.35 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.03 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.73 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.42 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jubilant Ingrevia Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jubilant Ingrevia Limited (2020–2025)

The table below shows the annual total liabilities of Jubilant Ingrevia Limited from 2020 to 2025.

Year Total Liabilities Change
2025-03-31 Rs21.05 Billion
≈ $227.61 Million
+5.53%
2024-03-31 Rs19.94 Billion
≈ $215.69 Million
+25.23%
2023-03-31 Rs15.93 Billion
≈ $172.24 Million
+16.76%
2022-03-31 Rs13.64 Billion
≈ $147.52 Million
-6.29%
2021-03-31 Rs14.56 Billion
≈ $157.42 Million
+878344.18%
2020-03-31 Rs1.66 Million
≈ $17.92K
--

About Jubilant Ingrevia Limited

NSE:JUBLINGREA India Specialty Chemicals
Market Cap
$977.68 Million
Rs90.40 Billion INR
Market Cap Rank
#8702 Global
#432 in India
Share Price
Rs573.20
Change (1 day)
+2.65%
52-Week Range
Rs541.30 - Rs763.80
All Time High
Rs859.20
About

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing servic… Read more